RxDoctor Payments Data

Tony Dipalma, DO

Family Medicine · Grove City, OHNPI 1467665117

Payments from drug & device makers

$6,588in general payments, 2019–2025

Across 404 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$320
  • Lilly USA, LLC$287
  • AstraZeneca$261
  • GSK$235
  • Novo Nordisk$224
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$6,576100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)83$1,018
Pfizer19$320
Lilly USA, LLC18$287
AstraZeneca15$261
GSK15$235
Novo Nordisk13$224
Merck12$216
Takeda Pharmaceuticals U.S.A., Inc.16$209
Boehringer Ingelheim13$206
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$196
Astellas Pharma US Inc11$193
Amgen11$191
Supernus Pharmaceuticals, Inc.9$190
Corium, LLC10$176
Axsome Therapeutics, Inc.7$172
Abbott9$166
Bayer8$144
Neos Therapeutics, LP7$118
Sanofi-aventis U.S. LLC7$116
Johnson & Johnson7$115
Xeris Pharmaceuticals, Inc.5$109
Teva Pharmaceuticals USA, Inc.8$104
Amarin Pharma, Inc.6$101
Otsuka America Pharmaceutical, Inc.5$98
Dexcom, Inc.3$88
Exact Sciences4$88
Kowa Pharmaceuticals America, Inc.6$82
Novartis5$71
E.r. Squibb & Sons, L.L.C.5$71
Ironshore Pharmaceuticals Inc.4$65
Vanda Pharmaceuticals Inc.2$65
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$65
Cranial Technologies, Inc4$61
Verona Pharma, Inc.3$59
Lundbeck LLC3$58
Sanofi Pasteur Inc.3$49
Arbor Pharmaceuticals, Inc.3$49
Corcept Therapeutics2$44
Endo Pharmaceuticals Inc.2$37
Mayne Pharma Commercial LLC1$32
Mylan Specialty L.p.1$29
Biohaven Pharmaceuticals, Inc.2$27
Globus Medical1$26
Edwards Lifesciences1$24
Nevro Corp.1$23
Vivus LLC1$23
Tris Pharma Inc1$20
Actelion Pharmaceuticals US, Inc.1$20
Dynavax Technologies Corporation1$19
Shield Therapeutics Inc1$18
Phathom Pharmaceuticals, Inc.1$18
Collegium Pharmaceutical, Inc.1$17
Vertical Pharmaceuticals, LLC1$17
Tolmar, Inc.1$16
Scilex Pharmaceuticals Inc.1$16
Lucid Diagnostics Inc.1$16
Smith+Nephew1$16
Shire North American Group Inc1$15
Hologic Sales And Service, LLC1$15
Adlon Therapeutics L.p.1$15

How this compares

$6,588 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$71,296
Medicare patients
199
Services billed
762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin83$80,637
Synjardy XrEmpagliflozin/Metformin Hcl122$79,944
EliquisApixaban88$74,868
FarxigaDapagliflozin Propanediol79$56,438
OzempicSemaglutide59$52,993
XareltoRivaroxaban33$40,072
TrulicityDulaglutide25$39,705
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$33,181
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr70$31,935
MounjaroTirzepatide27$27,981
TradjentaLinagliptin28$17,977
JanuviaSitagliptin Phosphate16$15,857
InvokanaCanagliflozin17$14,381
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$13,051
Breo ElliptaFluticasone/Vilanterol17$12,935

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$206$178,558233 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$235$78,051126 claims
PfizerEliquis$320$74,86888 claims
Lilly USA, LLCTrulicity, Mounjaro$287$67,68652 claims
AstraZenecaFarxiga$261$56,43879 claims
Johnson & JohnsonXarelto, Invokana$115$54,45250 claims
Novo NordiskOzempic$224$52,99359 claims
MerckJanuvia, Janumet, Janumet Xr$216$34,40742 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Grove City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →